logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9789124 B1

PDFFull Text
Expired
Date of Patent:
Oct. 17, 2017

Filed:

Jul. 31, 2015

Extended-release formulation for reducing the frequency of urination and method of use thereof

Applicant:

Wellesley Pharmaceuticals, Llc, Newtown, PA (US);

Inventors:

David A. Dill, Newtown, PA (US);

Ilya A. Volfson, Newtown Square, PA (US);

Assignee:

WELLESLEY PHARMACEUTICALS, LLC, Newtown, PA (US);

Attorneys:

Ping Wang

Andrews Kurth Kenyon LLP

Primary Examiner:

Sarah Pihonak

Assistant Examiner:

Jason A Deck

Int. Cl.
CPC ...
A61K 31/616 (2006.01); A61K 31/192 (2006.01); A61K 31/56 (2006.01); A61K 31/18 (2006.01); A61K 31/167 (2006.01); A61K 45/06 (2006.01); A61K 31/164 (2006.01); A61K 31/473 (2006.01); A61K 9/28 (2006.01); A61K 31/122 (2006.01); A61K 31/216 (2006.01); A61K 31/4025 (2006.01); A61K 31/405 (2006.01); A61K 31/46 (2006.01); A61K 31/4725 (2006.01);
U.S. Cl.
CPC ...
A61K 31/616 (2013.01); A61K 9/284 (2013.01); A61K 9/2846 (2013.01); A61K 9/2866 (2013.01); A61K 31/122 (2013.01); A61K 31/164 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/405 (2013.01); A61K 31/4025 (2013.01); A61K 31/46 (2013.01); A61K 31/473 (2013.01); A61K 31/4725 (2013.01); A61K 31/56 (2013.01); A61K 45/06 (2013.01);
Abstract

A method for reducing the frequency of urination is disclosed. The method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising one or more analgesic agents and one or more α-blockers. In one embodiment, the one or more analgesic agents are formulated for extended-release.

Find Patent Forward Citations

Dill, David. (2017). Extended-release formulation for reducing the frequency of urination and method of use thereof (U.S. Patent No. 9789124). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9789124

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…